Article
Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity.
Antiviral therapy - 1 Jan 2007
Brochot Etienne, Duverlie Gilles, Castelain Sandrine, Morel Virginie, Wychowski Czeslaw, Dubuisson Jean, François Catherine
Abstract excerpt
BACKGROUND: The consensus therapy for chronic hepatitis C infection is based on a synergistic combination of pegylated interferon and ribavirin. The therapy leads to a sustained virological response in around 60% of infected patients. The mechanism by which this synergy occurs has not yet been elucidated. Several mechanisms of action have been proposed; one suggests that ribavirin, which is a nucleoside analogue,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
